Global Colon Cancer Association Launches Biomarker Testing Campaign at ASCO GI

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
The American Journal of Managed Care

SBRT Is a Standard for Colorectal Liver Metastases: Michael David Chuong, MD

Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...
The American Journal of Managed Care

New Treatments for Liver Metastases Improve Survival, Outcomes Across Age Groups: Yuman Fong, MD

Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...

RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Johnson & Johnson (NYSE:JNJ) today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal ...

‘It just didn’t feel real’: Why are younger people getting colon cancer?

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...
Amazon S3 on MSN

Patient #1 for non-surgical treatment for colorectal cancer

For many years, surgery was the only treatment for colorectal cancer. But now there’s a new option that’s changing care ...